Are the NCCN/SSO COVID-19 guidelines for delay in melanoma treatment associated with mortality risk?: Supplemental Files

Supplemental material for publication titled - "Are the NCCN/SSO COVID-19 guidelines for delay in melanoma treatment associated with mortality risk?" to be published in Journal of the American Academy of Dermatology《美国皮肤病学会杂志》（Journal of the American Academy of Dermatology）即将刊发的学术论文《美国国家综合癌症网络（National Comprehensive Cancer Network, NCCN）/美国外科肿瘤学会（Society of Surgical Oncology, SSO）COVID-19相关黑色素瘤治疗延迟指南是否与死亡风险相关？》的补充资料